Company Profile
LeMaitre Vascular Stock Price, News & Analysis
- Ticker:
- LMAT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, LeMaitre Vascular is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
91.95 USD (+3.77%)
Close
Last updated: June 23, 2026 at 00:00
2.1B USD
Market cap
Why the stock is moving
LMAT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
LeMaitre Vascular is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, LeMaitre Vascular is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
LeMaitre Vascular follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, LeMaitre Vascular sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of LeMaitre Vascular (LMAT)?
LeMaitre Vascular (LMAT) most recently closed at 91.95 USD, a +3.77% move versus the previous session.
What is the market cap of LeMaitre Vascular (LMAT)?
LeMaitre Vascular currently has a market capitalization of 2.1B USD on BioPharmSignal.
What does LeMaitre Vascular do?
LeMaitre Vascular is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is LMAT stock listed?
LeMaitre Vascular (LMAT) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, LeMaitre Vascular is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is LeMaitre?
LeMaitre Vascular is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is LeMaitre Vascular targeting with LeMaitre?
LeMaitre Vascular is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Vascular?
LeMaitre Vascular is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.